USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12091
Title: Pulmonary alveolar proteinosis: from house painting to diffuse lung disease
Authors: Chirita, George-Alexandru
Keywords: pulmonary alveolar proteinosis;diffuse lung disease;PAS positive;toxic exposure
Issue Date: 2020
Publisher: MedEspera
Citation: CHIRITA, George-Alexandru. Pulmonary alveolar proteinosis: from house painting to diffuse lung disease. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 44.
Abstract: Background. Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of periodic acid-Schiff (PAS)-positive lipoproteinaceous material within the alveoli resulting in hypoxemic respiratory failure. Secondary PAP due to heavy inhalation exposure to inorganic dusts causes a reduction in the number and clearance capacity of alveolar macrophages. Case report. We present you the case of a 42-year-old Sudanese patient with a 17-pack years smoking history who shows up at the hospital in December 2019 for dry cough, weight loss and exertional dyspnea. The onset of the symptoms started 2 months earlier, after using sandpaper on the walls while refurbishing his house. The initial diagnosis based on the clinical context and chest X-ray was pulmonary tuberculosis. However, the Acid-Fast Bacillus (AFB) smear was negative and the High-resolution CT showed a “crazy-paving” pattern. The blood count showed no evidence of hematologic malignancy or myelodysplastic syndrome. A flexible bronchoscopy to obtain bronchoalveolar lavage (BAL) fluid was performed. The examination of the BAL fluid showed the presence of PAS-positive material and the growth of E.coli colonies with no atypical cells found. Pulmonary function tests demonstrated a moderate reduction in the diffusing capacity for carbon monoxide (DLCO). : Using all of the findings, the diagnosis of secondary pulmonary alveolar proteinosis was established. The patient received antibiotic treatment with ceftriaxone and ciprofloxacin. Whole lung lavage under general anesthesia via a double-lumen endotracheal tube was performed, which proved to be effective. The patient was advised to stop smoking and a regular check twice a year was recommended. Conclusions. Secondary PAP represents less than 10% of the total cases of pulmonary proteinosis. Further tests should be performed to identify the exact etiology in this situation The particularity of the case comes from the short exposure to the toxic, as well as its ethnic background.
URI: https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf
http://repository.usmf.md/handle/20.500.12710/12091
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
Pulmonary_alveolar_proteinosis_from_house_painting_to_diffuse_lung_disease.pdf438.71 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback